Hexaware Technologies: Quotes, News

BSE 470.750 (0.00%)

NSE 470.80 (0.00%)

Maruti Suzuki India: Quotes, News

BSE 12685.00217.5 (-1.71%)

NSE 12711.00247 (-1.94%)

Hexaware Tech:

Asit C. Mehta has recommended hold rating on Hexaware Technologies with a target of Rs 107, in its December 7, 2012 research report.

" Hexaware Technologies Ltd. (Hexaware) revised their revenue growth guidance. The revenue growth rate (in $ terms) has been revised downwards to 18% from the earlier estimate of 20% YoY."

Maruti Suzuki:

Sudarshan Sukhani, s2analytics.com advises traders to buy Maruti Suzuki and M&M on decline.

Sukhani told CNBC-TV18, "Maruti Suzuki and Mahindra & Mahindra both are excellent stocks, both are good. I have been very upbeat on M&M even on the days when it was declining; I had suggested these are the buying opportunities."

Thirumalai Chem:

Sunidhi Securities is bullish on Thirumalai Chemicals and has recommended buy rating on the stock with a target of Rs 145 in its December 7, 2012 research report.

"Incorporated in 1976, Thirumalai Chemicals (TCL), started production of Phthalic Anhydride in in Ranipet, in South India. Since then, it has grown into a diverse and respected enterprise, rapidly expanding into the manufacture of many other critical industrial chemicals: Maleic Anhydride, Fumaric Acid and Malic Acid and various Fine Chemicals and Derivatives. Today TCL ranks among the largest producers in the world in all its core products. TCL has a strong manufacturing base capable of delivering quality products, with excellent logistics and technical support, at competitive prices."

MphasiS:

Kotak Securities is bearish on MphasiS and recommends reduce rating on the stock.

MphasiS Ltd's September Quarter results were below expectations. Dollar revenues for the firm were down by about 2%. Direct business reported flat revenues, much lower than expectations, Kotak Securities said in the research report.

GoodReturns.in

DISCLAIMER: GoodReturns provides you with information covering shares, futures and options based on broker's reports as stated on various media. Investors are, however, warned that they should NOT take any buy or sell decision based on these views expressed in the article. Investors should consult their own financial and share advisors before taking purchase or sale decisions. GoodReturns does not take any responsibility for any losses incurred by investors who take their cues from the above article.